{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:54:46Z","timestamp":1774353286997,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,22]]},"DOI":"10.7759\/cureus.50964","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T19:00:14Z","timestamp":1703271614000},"source":"Crossref","is-referenced-by-count":2,"title":["Harnessing the Microbiome: A Comprehensive Review on Advancing Therapeutic Strategies for Rheumatic Diseases"],"prefix":"10.7759","author":[{"given":"Priyadarshini","family":"Bhattacharjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim Arif","family":"Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-016-0614-8","article-title":"The microbiome: a revolution in treatment for rheumatic diseases?","volume":"18","author":"Rosenbaum JT","year":"2016","unstructured":"Rosenbaum JT, Asquith MJ. The microbiome: a revolution in treatment for rheumatic diseases?. Curr Rheumatol Rep. 2016, 18:62. 10.1007\/s11926-016-0614-8","journal-title":"Curr Rheumatol Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11070625","article-title":"Exploring the oral microbiome in rheumatic diseases, state of art and future prospective in personalized medicine with an AI Approach","volume":"11","author":"Bellando-Randone S","year":"2021","unstructured":"Bellando-Randone S, Russo E, Venerito V, Matucci-Cerinic M, Iannone F, Tangaro S, Amedei A. Exploring the oral microbiome in rheumatic diseases, state of art and future prospective in personalized medicine with an AI Approach. J Pers Med. 2021, 11:625. 10.3390\/jpm11070625","journal-title":"J Pers Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.68","article-title":"The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions","volume":"12","author":"Abdollahi-Roodsaz S","year":"2016","unstructured":"Abdollahi-Roodsaz S, Abramson SB, Scher JU. The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions. Nat Rev Rheumatol. 2016, 12:446-55. 10.1038\/nrrheum.2016.68","journal-title":"Nat Rev Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102530","article-title":"Microbiota and metabolites in rheumatic diseases","volume":"19","author":"Tong Y","year":"2020","unstructured":"Tong Y, Marion T, Schett G, Luo Y, Liu Y. Microbiota and metabolites in rheumatic diseases. Autoimmun Rev. 2020, 19:102530. 10.1016\/j.autrev.2020.102530","journal-title":"Autoimmun Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.39259","article-title":"Microbiome in inflammatory arthritis and human rheumatic diseases","volume":"68","author":"Scher JU","year":"2016","unstructured":"Scher JU, Littman DR, Abramson SB. Microbiome in inflammatory arthritis and human rheumatic diseases. Arthritis Rheumatol. 2016, 68:35-45. 10.1002\/art.39259","journal-title":"Arthritis Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.711788","article-title":"Probiotic supplementation for rheumatoid arthritis: a promising adjuvant therapy in the gut microbiome era","volume":"12","author":"Ferro M","year":"2021","unstructured":"Ferro M, Charneca S, Dourado E, Guerreiro CS, Fonseca JE. Probiotic supplementation for rheumatoid arthritis: a promising adjuvant therapy in the gut microbiome era. Front Pharmacol. 2021, 12:711788. 10.3389\/fphar.2021.711788","journal-title":"Front Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/nu12103155","article-title":"Beverages in rheumatoid arthritis: what to prefer or to avoid","volume":"12","author":"Dey M","year":"2020","unstructured":"Dey M, Cutolo M, Nikiphorou E. Beverages in rheumatoid arthritis: what to prefer or to avoid. Nutrients. 2020, 12:3155. 10.3390\/nu12103155","journal-title":"Nutrients"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4517","article-title":"Current understanding of the human microbiome","volume":"24","author":"Gilbert JA","year":"2018","unstructured":"Gilbert JA, Blaser MJ, Caporaso JG, Jansson JK, Lynch SV, Knight R. Current understanding of the human microbiome. Nat Med. 2018, 24:392-400. 10.1038\/nm.4517","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216631","article-title":"The microbiome in rheumatology: where are we and where should we go?","volume":"79","author":"Manasson J","year":"2020","unstructured":"Manasson J, Blank RB, Scher JU. The microbiome in rheumatology: where are we and where should we go?. Ann Rheum Dis. 2020, 79:727-33. 10.1136\/annrheumdis-2019-216631","journal-title":"Ann Rheum Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2011.05.001","article-title":"Microbiome influences on insect host vector competence","volume":"27","author":"Weiss B","year":"2011","unstructured":"Weiss B, Aksoy S. Microbiome influences on insect host vector competence. Trends Parasitol. 2011, 27:514-22. 10.1016\/j.pt.2011.05.001","journal-title":"Trends Parasitol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12200","article-title":"Harness the functions of gut microbiome in tumorigenesis for cancer treatment","volume":"41","author":"Lee MH","year":"2021","unstructured":"Lee MH. Harness the functions of gut microbiome in tumorigenesis for cancer treatment. Cancer Commun (Lond). 2021, 41:937-67. 10.1002\/cac2.12200","journal-title":"Cancer Commun (Lond)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2022.102415","article-title":"Molecular tools for probing the microbiome","volume":"76","author":"Torres MT","year":"2022","unstructured":"Torres MT, de la Fuente-Nunez C. Molecular tools for probing the microbiome. Curr Opin Struct Biol. 2022, 76:102415. 10.1016\/j.sbi.2022.102415","journal-title":"Curr Opin Struct Biol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2014.08.004","article-title":"Diet, gut microbes, and genetics in immune function: can we leverage our current knowledge to achieve better outcomes in inflammatory bowel diseases?","volume":"31","author":"Leone VA","year":"2014","unstructured":"Leone VA, Cham CM, Chang EB. Diet, gut microbes, and genetics in immune function: can we leverage our current knowledge to achieve better outcomes in inflammatory bowel diseases?. Curr Opin Immunol. 2014, 31:16-23. 10.1016\/j.coi.2014.08.004","journal-title":"Curr Opin Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2017.1373828","article-title":"Immunomodulatory interplay of the microbiome and therapy of rheumatic diseases","volume":"46","author":"Ostrov BE","year":"2017","unstructured":"Ostrov BE, Amsterdam D. Immunomodulatory interplay of the microbiome and therapy of rheumatic diseases. Immunol Invest. 2017, 46:769-92. 10.1080\/08820139.2017.1373828","journal-title":"Immunol Invest"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/f10010042","article-title":"Forest tree microbiomes and associated fungal endophytes: functional roles and impact on forest health","volume":"10","author":"Terhonen E","year":"2019","unstructured":"Terhonen E, Blumenstein K, Kovalchuk A, Asiegbu, FO. Forest tree microbiomes and associated fungal endophytes: functional roles and impact on forest health. Forests. 2019, 10:42. 10.3390\/f10010042","journal-title":"Forests"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00033.2020","article-title":"Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease","volume":"52","author":"Golonka RM","year":"2020","unstructured":"Golonka RM, Saha P, Yeoh BS, Chattopadhyay S, Gewirtz AT, Joe B, Vijay-Kumar M. Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease. Physiol Genomics. 2020, 52:217-21. 10.1152\/physiolgenomics.00033.2020","journal-title":"Physiol Genomics"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/368736","article-title":"Harnessing the microbiome to enhance cancer immunotherapy","volume":"2015","author":"Nelson MH","year":"2015","unstructured":"Nelson MH, Diven MA, Huff LW, Paulos CM. Harnessing the microbiome to enhance cancer immunotherapy. J Immunol Res. 2015, 2015:368736. 10.1155\/2015\/368736","journal-title":"J Immunol Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00512-7","article-title":"Leveraging diet to engineer the gut microbiome","volume":"18","author":"Wolter M","year":"2021","unstructured":"Wolter M, Grant ET, Boudaud M, Steimle A, Pereira GV, Martens EC, Desai MS. Leveraging diet to engineer the gut microbiome. Nat Rev Gastroenterol Hepatol. 2021, 18:885-902. 10.1038\/s41575-021-00512-7","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuw045","article-title":"Intestinal microbiome landscaping: insight in community assemblage and implications for microbial modulation strategies","volume":"41","author":"Shetty SA","year":"2017","unstructured":"Shetty SA, Hugenholtz F, Lahti L, Smidt H, de Vos WM. Intestinal microbiome landscaping: insight in community assemblage and implications for microbial modulation strategies. FEMS Microbiol Rev. 2017, 41:182-99. 10.1093\/femsre\/fuw045","journal-title":"FEMS Microbiol Rev"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41477-020-00830-9","article-title":"Emerging strategies for precision microbiome management in diverse agroecosystems","volume":"7","author":"French E","year":"2021","unstructured":"French E, Kaplan I, Iyer-Pascuzzi A, Nakatsu CH, Enders L. Emerging strategies for precision microbiome management in diverse agroecosystems. Nat Plants. 2021, 7:256-67. 10.1038\/s41477-020-00830-9","journal-title":"Nat Plants"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101528","article-title":"Microbes, helminths, and rheumatic diseases","volume":"34","author":"Rocha FAC","year":"2020","unstructured":"Rocha FAC, Duarte-Monteiro AM, da Mota LMH, Pinto ACMD, Fonseca JE. Microbes, helminths, and rheumatic diseases. Best Pract Res Clin Rheumatol. 2020, 34:101528. 10.1016\/j.berh.2020.101528","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.61","article-title":"Toll-like receptors and chronic inflammation in rheumatic diseases: new developments","volume":"12","author":"Joosten LA","year":"2016","unstructured":"Joosten LA, Abdollahi-Roodsaz S, Dinarello CA, O'Neill L, Netea MG. Toll-like receptors and chronic inflammation in rheumatic diseases: new developments. Nat Rev Rheumatol. 2016, 12:344-57. 10.1038\/nrrheum.2016.61","journal-title":"Nat Rev Rheumatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1109","article-title":"Therapeutic strategies for rheumatoid arthritis","volume":"2","author":"Smolen JS","year":"2003","unstructured":"Smolen JS, Steiner G. Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov. 2003, 2:473-88. 10.1038\/nrd1109","journal-title":"Nat Rev Drug Discov"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.201","article-title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","volume":"16","author":"Schwartz DM","year":"2017","unstructured":"Schwartz DM, Kanno Y, Villarino A, Ward M, Gadina M, O'Shea JJ. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat Rev Drug Discov. 2017, 16:843-62. 10.1038\/nrd.2017.201","journal-title":"Nat Rev Drug Discov"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X19844632","article-title":"The role of microbiome in rheumatoid arthritis treatment","volume":"11","author":"Bodkhe R","year":"2019","unstructured":"Bodkhe R, Balakrishnan B, Taneja V. The role of microbiome in rheumatoid arthritis treatment. Ther Adv Musculoskelet Dis. 2019, 11:1759720X19844632. 10.1177\/1759720X19844632","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11061582","article-title":"Using the microbiome as a regenerative medicine strategy for autoimmune diseases","volume":"11","author":"Williams KL","year":"2023","unstructured":"Williams KL, Enslow R, Suresh S, Beaton C, Hodge M, Brooks AE. Using the microbiome as a regenerative medicine strategy for autoimmune diseases. Biomedicines. 2023, 11:1582. 10.3390\/biomedicines11061582","journal-title":"Biomedicines"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03995-x","article-title":"The oral microbiome in autoimmune diseases: friend or foe?","volume":"21","author":"Huang X","year":"2023","unstructured":"Huang X, Huang X, Huang Y, et al.. The oral microbiome in autoimmune diseases: friend or foe?. J Transl Med. 2023, 21:211. 10.1186\/s12967-023-03995-x","journal-title":"J Transl Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4103\/injr.injr_210_20","article-title":"The emerging world of microbiome in autoimmune disorders: opportunities and challenges","volume":"16","author":"Mangalam AK","year":"2021","unstructured":"Mangalam AK, Yadav M, Yadav R. The emerging world of microbiome in autoimmune disorders: opportunities and challenges. Indian J Rheumatol. 2021, 16:57-72. 10.4103\/injr.injr_210_20","journal-title":"Indian J Rheumatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00589-21","article-title":"The age of next-generation therapeutic-microbe discovery: exploiting microbe-microbe and host-microbe interactions for disease prevention","volume":"90","author":"Cruz N","year":"2022","unstructured":"Cruz N, Abernathy GA, Dichosa AE, Kumar A. The age of next-generation therapeutic-microbe discovery: exploiting microbe-microbe and host-microbe interactions for disease prevention. Infect Immun. 2022, 90:e0058921. 10.1128\/iai.00589-21","journal-title":"Infect Immun"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-4-72","article-title":"\"Who owns your poop?\": insights regarding the intersection of human microbiome research and the ELSI aspects of biobanking and related studies","volume":"4","author":"Hawkins AK","year":"2011","unstructured":"Hawkins AK, O'Doherty KC. \"Who owns your poop?\": insights regarding the intersection of human microbiome research and the ELSI aspects of biobanking and related studies. BMC Med Genomics. 2011, 4:72. 10.1186\/1755-8794-4-72","journal-title":"BMC Med Genomics"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1186\/2049-2618-2-12","article-title":"Harnessing microbiome and probiotic research in sub-Saharan Africa: recommendations from an African workshop","volume":"2","author":"Reid G","year":"2014","unstructured":"Reid G, Nduti N, Sybesma W, et al.. Harnessing microbiome and probiotic research in sub-Saharan Africa: recommendations from an African workshop. Microbiome. 2014, 2:12. 10.1186\/2049-2618-2-12","journal-title":"Microbiome"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202006104","article-title":"The microbiome meets nanotechnology: opportunities and challenges in developing new diagnostic devices","volume":"33","author":"Fuentes-Chust C","year":"2021","unstructured":"Fuentes-Chust C, Parolo C, Rosati G, et al.. The microbiome meets nanotechnology: opportunities and challenges in developing new diagnostic devices. Adv Mater. 2021, 33:e2006104. 10.1002\/adma.202006104","journal-title":"Adv Mater"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.5b07826","article-title":"Tools for the microbiome: nano and beyond","volume":"10","author":"Biteen JS","year":"2016","unstructured":"Biteen JS, Blainey PC, Cardon ZG, et al.. Tools for the microbiome: nano and beyond. ACS Nano. 2016, 10:6-37. 10.1021\/acsnano.5b07826","journal-title":"ACS Nano"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.15628.3","article-title":"Improving causality in microbiome research: can human genetic epidemiology help?","volume":"4","author":"Wade KH","year":"2019","unstructured":"Wade KH, Hall LJ. Improving causality in microbiome research: can human genetic epidemiology help?. Wellcome Open Res. 2019, 4:199. 10.12688\/wellcomeopenres.15628.3","journal-title":"Wellcome Open Res"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2729-3","article-title":"Host-microbiota maladaptation in colorectal cancer","volume":"585","author":"Janney A","year":"2020","unstructured":"Janney A, Powrie F, Mann EH. Host-microbiota maladaptation in colorectal cancer. Nature. 2020, 585:509-17. 10.1038\/s41586-020-2729-3","journal-title":"Nature"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12020238","article-title":"A taxonomy-agnostic approach to targeted microbiome therapeutics-leveraging principles of systems biology","volume":"12","author":"Brumfield KD","year":"2023","unstructured":"Brumfield KD, Cox P, Geyer J, Goepp J. A taxonomy-agnostic approach to targeted microbiome therapeutics-leveraging principles of systems biology. Pathogens. 2023, 12:238. 10.3390\/pathogens12020238","journal-title":"Pathogens"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-022-01173-1","article-title":"Harnessing the microbiome to prevent global biodiversity loss","volume":"7","author":"Peixoto RS","year":"2022","unstructured":"Peixoto RS, Voolstra CR, Sweet M, et al.. Harnessing the microbiome to prevent global biodiversity loss. Nat Microbiol. 2022, 7:1726-35. 10.1038\/s41564-022-01173-1","journal-title":"Nat Microbiol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-022-00475-4","article-title":"Artificial intelligence in rheumatoid arthritis: current status and future perspectives: a state-of-the-art review","volume":"9","author":"Momtazmanesh S","year":"2022","unstructured":"Momtazmanesh S, Nowroozi A, Rezaei N. Artificial intelligence in rheumatoid arthritis: current status and future perspectives: a state-of-the-art review. Rheumatol Ther. 2022, 9:1249-304. 10.1007\/s40744-022-00475-4","journal-title":"Rheumatol Ther"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.144998","article-title":"Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis","volume":"70","author":"Buch MH","year":"2011","unstructured":"Buch MH, Smolen JS, Betteridge N, et al.. Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis. 2011, 70:909-20. 10.1136\/ard.2010.144998","journal-title":"Ann Rheum Dis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.07.012","article-title":"International consensus: what else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: the unmet needs and the clinical grey zone in autoimmune disease management","volume":"16","author":"Giacomelli R","year":"2017","unstructured":"Giacomelli R, Afeltra A, Alunno A, et al.. International consensus: what else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: the unmet needs and the clinical grey zone in autoimmune disease management. Autoimmun Rev. 2017, 16:911-24. 10.1016\/j.autrev.2017.07.012","journal-title":"Autoimmun Rev"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen JS","year":"2023","unstructured":"Smolen JS, Landew\u00e9 RB, Bergstra SA, et al.. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023, 82:3-18. 10.1136\/ard-2022-223356","journal-title":"Ann Rheum Dis"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.071092","article-title":"Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)","volume":"66","author":"Verstappen SM","year":"2007","unstructured":"Verstappen SM, Jacobs JW, van der Veen MJ, et al.. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis. 2007, 66:1443-9. 10.1136\/ard.2007.071092","journal-title":"Ann Rheum Dis"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13184","article-title":"Porphyromonas gingivalis in the tongue biofilm is associated with clinical outcome in rheumatoid arthritis patients","volume":"194","author":"Ceccarelli F","year":"2018","unstructured":"Ceccarelli F, Orr\u00f9 G, Pilloni A, et al.. Porphyromonas gingivalis in the tongue biofilm is associated with clinical outcome in rheumatoid arthritis patients. Clin Exp Immunol. 2018, 194:244-52. 10.1111\/cei.13184","journal-title":"Clin Exp Immunol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219009","article-title":"Streptococcus species enriched in the oral cavity of patients with RA are a source of peptidoglycan-polysaccharide polymers that can induce arthritis in mice","volume":"80","author":"Moentadj R","year":"2021","unstructured":"Moentadj R, Wang Y, Bowerman K, et al.. Streptococcus species enriched in the oral cavity of patients with RA are a source of peptidoglycan-polysaccharide polymers that can induce arthritis in mice. Ann Rheum Dis. 2021, 80:573-81. 10.1136\/annrheumdis-2020-219009","journal-title":"Ann Rheum Dis"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2020.04.040","article-title":"Analysis of subgingival microbiome of periodontal disease and rheumatoid arthritis in Chinese: a case-control study","volume":"27","author":"Liu X","year":"2020","unstructured":"Liu X, Tian K, Ma X, Wang S, Luo C, Du Q. Analysis of subgingival microbiome of periodontal disease and rheumatoid arthritis in Chinese: a case-control study. Saudi J Biol Sci. 2020, 27:1835-42. 10.1016\/j.sjbs.2020.04.040","journal-title":"Saudi J Biol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/211534-harnessing-the-microbiome-a-comprehensive-review-on-advancing-therapeutic-strategies-for-rheumatic-diseases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:12Z","timestamp":1707509532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/211534-harnessing-the-microbiome-a-comprehensive-review-on-advancing-therapeutic-strategies-for-rheumatic-diseases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,22]]},"references-count":45,"URL":"https:\/\/doi.org\/10.7759\/cureus.50964","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,22]]}}}